Skip to main content

Table 1 Summary of patient demographics

From: Dietary ω-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD

All patients n = 82

 

Non-COPD (n = 50)

COPD (n = 32)

Characteristics

Resection for thoracic malignancy

(n = 17)

End stage lung disease other than COPD

(n = 33)

 

Pathology

1. IPF (n = 17) (51.5%)

2. Pulmonary hypertension (n = 4) (12.1%)

3. Eisenmenger’s syndrome (n = 2) (6.1%)

4. BOS (n = 2) (6.1%)

5. Bronchiectasis (n = 2) (6.1%)

6. Other (n = 6) (18.2%)

1. Emphysema or COPD (n = 28) (87.5%)

2. α1-antitrypsin deficiency (n = 4) (12.5%)

Sex (n) Female/Male

13/4

11/22

13/19

Mean age (years) (SD)

61.0 (9.7)

55.5 (13.4)

59.1 (8.7)

Mean BMI (kg/m2)(SD)

25.0 (5.2)

25.4 (5.3)

23.8 (4.0)

Smokers/non-smokers/unk

(% smokers)

12/2/3

(70.5%)

15/9/9

(45%)

28/2/2

(87.5%)

  1. COPD Chronic obstructive pulmonary disease, IPF Idiopathic pulmonary fibrosis, BOS Bronchiolitis obliterans syndrome, unk data Unknown, SD Standard deviation, BMI Body mass index